| Dr Samuel J Rheinhardt, MD | |
|
400 1st Capitol Dr Ste 201, Saint Charles, MO 63301-2882 | |
| (636) 669-2332 | |
| Not Available |
| Full Name | Dr Samuel J Rheinhardt |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 9 Years |
| Location | 400 1st Capitol Dr Ste 201, Saint Charles, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174903488 | NPI | - | NPPES |
| 11018234A | Other | IN | MEDICAL RESIDENCY PERMIT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 11018234A (Indiana) | Secondary |
| 208C00000X | Colon & Rectal Surgery | 125.075514 (Illinois) | Secondary |
| 208600000X | Surgery | 2021023199 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - St Louis | Richmond heights, MO | Hospital |
| Ssm St Clare Health Center | Fenton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Health Care Group | 0143608372 | 678 |
News Archive
Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.
Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
A clinical trial that aims to speed up the study of new treatments for certain subtypes of breast cancer now has a designated study site at the Diane O'Connor Thompson Breast Center at the University of Colorado Hospital.
Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.
The medication tamoxifen, best known as a treatment for breast cancer, dramatically reduces symptoms of the manic phase of bipolar disorder more quickly than many standard medications for the mental illness, a new study shows.
› Verified 6 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.
Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
A clinical trial that aims to speed up the study of new treatments for certain subtypes of breast cancer now has a designated study site at the Diane O'Connor Thompson Breast Center at the University of Colorado Hospital.
Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.
The medication tamoxifen, best known as a treatment for breast cancer, dramatically reduces symptoms of the manic phase of bipolar disorder more quickly than many standard medications for the mental illness, a new study shows.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel J Rheinhardt, MD Po Box 955534, Saint Louis, MO 63195-5534 Ph: () - | Dr Samuel J Rheinhardt, MD 400 1st Capitol Dr Ste 201, Saint Charles, MO 63301-2882 Ph: (636) 669-2332 |
News Archive
Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.
Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
A clinical trial that aims to speed up the study of new treatments for certain subtypes of breast cancer now has a designated study site at the Diane O'Connor Thompson Breast Center at the University of Colorado Hospital.
Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.
The medication tamoxifen, best known as a treatment for breast cancer, dramatically reduces symptoms of the manic phase of bipolar disorder more quickly than many standard medications for the mental illness, a new study shows.
› Verified 6 days ago
Dr. Thomas A Schneider Ii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr, Saint Charles, MO 63301 Phone: 636-940-5710 Fax: 636-669-2401 | |
Jennifer Marie Laplante, MD, PHD Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr Ste 201, Saint Charles, MO 63301 Phone: 636-669-2332 | |
Dr. Aislinn Sue Vaughan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1475 Kisker Rd, Suite 185, Saint Charles, MO 63304 Phone: 636-498-5800 Fax: 636-669-2401 | |
Dr. David L Mccollister, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr, Saint Charles, MO 63301 Phone: 636-669-2332 Fax: 636-669-2401 | |
Dr. Patrick Anthony Nero, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr, Suite 201, Saint Charles, MO 63301 Phone: 636-669-2332 | |
Pamela Sue Peigh, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 636-947-5662 |